References
- Rizetti MC, Liberini P, Zarattini G, Catalani S, Pazzaglia U, Apostoli P, Padovani A. Loss of sight and sound. Could it be the hip? Lancet 2009;272:1052.
- Berk L, Burchenal JH, Castle WB. Erythropoietic effect of cobalt in patients with or without anemia. N Eng J Med 1949;240:754–762.
- Gross RT, Kriss JP, Spaet TH. Hematopoietic and goitrogenic effects of cobaltous chloride in patients with sickle cell anemia. Am J Dis Child 1954;88:284–290.
- Gross RT, Kriss JP, Spaet TH. The hematopoietic and goitrogenic effects of cobaltous chloride in patients with sickle cell anemia. Peds 1955;15:284–294.
- Kriss JP, Carnes WH, Gross RT. Hypothyroidism and thyroid hyperplasia in patients treated with cobalt. JAMA 1955;157:117–121.
- Robey JS, Veazel PM, Crawford JD. Cobalt-induced myxedema. N Eng J Med 1956;255:955–957.
- Chamberlain JL. Thyroid enlargement probably induced by cobalt. J Peds 1961;59:81–86.
- Washburn TC, Kaplan E. Cobalt therapy and goiter. Clin Peds 1964;3: 89–92.
- Bowie EA, Hurley PJ. Cobalt chloride in the treatment of refractory anaemia in patients undergoing long-term haemodialysis. Aust NZ J Med 1975;5:306–314.
- Licht A. Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. Isr J Med Sci 1972;8: 61–66.
- Schirrmacher UOE. Case of cobalt poisoning. Br Med J 1967;1: 544–545.
- McDermott PH, Delaney RL, Egan JD, Sullivan JF. Myocardosis and cardiac failure in men. JAMA 1966;198:253–256.
- Kesteloot H, Roelandt J, Willems J, Claes JH, Joossens JV. An enquiry into the role of cobalt in the heart disease of chronic beer drinkers. J Am Heart Assoc 1968;37:854–864.
- Alexander CS. Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases. Am J Med 1972;53: 395–417.
- Seghizzi P, D’Adda F, Borleri D, Barbic F, Mosconi G. Cobalt myocardiopathy. A critical review of literature. Sci Total Environ 1994;180:105–109.
- Tower SS. Arthroprosthetic cobaltism: Neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: A case report. J Bone Joint Surg 2010;92:2847–2851.
- Pelclova D, Sklensky M, Janicek P, Lach K: Severe cobalt intoxication following hip replacement revision: Clinical ceatures and outcome. Clin Tox 2012;50:262–265.
- Steens W, von Foerster G, Katzer A. Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip – a case report. Acta Orthopaedica 2006;77:830–832.
- Oldenburg M, Wegner R, Baur X. Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. J Arthroplasty 2009;24:502.e15–e19.
- Ikeda T, Takahashi K, Kabata T, Sakagoshi D, Tomita K, Yamada M. Polyneuropathy caused by cobalt-chromium metalossis after total hip replacement. Muscle Nerve 2010;42:140–143.
- Anon. Chromium (VI) compounds. IARC monographs on the evaluation of carcinogenic risks to humans. 2012;100:147–167.
- Howie DW, Rogers SD, McGee MA, Haynes DDR. Biological effects of cobalt chrome in cell and animal models. Clin Ortho Relat Res 1996;329s:s217–s232.
- Newton AW, Ranganath L, Armstrong C, Peter V, Roberts NB. Differential distribution of cobalt, chromium, and nickel between whole blood, plasma and urine in patients after metal-on-metal (MoM) hip arthroplasty. J Orthop Res 2012;30:1640–1646.
- Walter LR, Marel E, Harbury R, Wearne J. Distribution of chromium and cobalt ions in various blood fractions after resurfacing hip arthroplasty. Arthroplasty 2008;23:814–822.
- Kwon YM, Thomas P, Summer B, Pandit H, Taylor A, Beard D, et al. Lymphocyte proliferation responses in patients with pseudotumors following metal-on-metal hip resurfacing arthroplasty. J Orthop Res 2010;28:444–450.
- Medicines and Healthcare products Regulatory Agency 2012. Medical Device Alert re: All meta-on-metal (MoM) hip replacements. MDA/2012/036, Pgs. 1–7. http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON155761 (Accessed March 3, 2012).